Telemedicine and support groups could be used to improve adherence to treatment and health‐related quality of life in patients affected by inflammatory skin conditions during the COVID‐19 pandemic

Marasca, Claudio; Ruggiero, Angelo; Fontanella, Giuseppina; Ferrillo, Maria; Fabbrocini, Gabriella; Villani, Alessia

doi:10.1111/ced.14245

Cited by 36 publications

(33 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…7 Merthens et al 4 in their 14-year retrospective study in UK, based on 40201 teleconsultations, revealed that teledermatology service had been useful to prevent 16 282 face-to-face appointments. In line with literature, [8][9][10] our questionnaire showed that the majority of patients (92.3%) appreciated the visits and the attention that physicians gave them, as well as the treatment received, with 90.3 % assessing they will continue to consult the same dermatologists. This is the first study assessing the grade of satisfaction of patients affected by acne disease after video-call visits.…”

supporting

confidence: 84%

Teledermatology for acne during COVID‐19: high patients’ satisfaction in spite of the emergency

Ruggiero

Megna

Annunziata

et al. 2020

Acad Dermatol Venereol

Self Cite

View full text Add to dashboard Cite

supporting

confidence: 84%

Teledermatology for acne during COVID‐19: high patients’ satisfaction in spite of the emergency

Ruggiero

Megna

Annunziata

et al. 2020

Acad Dermatol Venereol

Self Cite

View full text Add to dashboard Cite

“…Participants may have improved their ART adherence out of health concerns or because they were home more, or possibly other reasons. 40 , 41 This positive change occurred despite interruption in accessing medications. It is possible that this increase in adherence is a blip and will subside, especially if barriers in accessing medications are not resolved.…”

Section: Discussionmentioning

confidence: 97%

Intersecting Pandemics: Impact of SARS-CoV-2 (COVID-19) Protective Behaviors on People Living With HIV, Atlanta, Georgia

Kalichman

Eaton

Berman

et al. 2020

JAIDS Journal of Acquired Immune Deficiency Syndromes

View full text Add to dashboard Cite

Background: COVID-19 and its social responses threaten the health of people living with HIV. We conducted a rapid-response interview to assess COVID-19 protective behaviors of people living with HIV and the impact of their responses on HIV-related health care. Method: Men and women living with HIV (N = 162) aged 20–37 years participating in a longitudinal study of HIV treatment and care completed routine study measures and an assessment of COVID-19–related experiences. Results: At baseline, most participants demonstrated HIV viremia, markers indicative of renal disorders, and biologically confirmed substance use. At follow-up, in the first month of responding to COVID-19, engaging in more social distancing behaviors was related to difficulty accessing food and medications and increased cancelation of health care appointments, both by self and providers. We observed antiretroviral therapy adherence had improved during the initial month of COVID-19 response. Conclusions: Factors that may pose added risk for COVID-19 severity were prevalent among people living with HIV, and those with greater risk factors did not practice more COVID-19 protective behaviors. Social distancing and other practices intended to mitigate the spread of COVID-19 interfered with HIV care, and impeded access to food and medications, although an immediate adverse impact on medication adherence was not evident. These results suggest social responses to COVID-19 adversely impacted the health care of people living with HIV, supporting continued monitoring to determine the long-term effects of co-occurring HIV and COVID-19 pandemics.

show abstract

“…Moreover, these papers have published many aspects from patients' cutaneous manifestations with COVID-19 to economic impact [40] and protective measures for the cutaneous system during COVID-19 exposure [41][42][43][44][45][46][47][48][49][50][51][52]. Another aspect are skin damages in healthcare workers [42,49,[53][54][55][56][57][58], medical education and telemedicine during the pandemic [59][60][61][62], the use of immunomodulators [63,64]; immunosuppressors and immunobiological agents in dermatology [65], as well as, in rheumatology skin conditions [63,66,67].…”

Section: Introductionmentioning

confidence: 99%

Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms

et al. 2020

View full text Add to dashboard Cite

Background SARS-Cov-2 is a single-stranded RNA virus, a Betacoronavirus, composed of 16 non-structural proteins, with specific roles in replication of coronaviruses. The pathogenesis of COVID-19 is not yet fully understood. The virus and host factors interplay among distinct outcomes of infected patients. Methods Using MeSH (Medical Subject Headings) in PubMed, authors searched for articles cotaining information on COVID-19 and the skin. Results The pathophysiology of the disease is multifactorial: association with innate immune response, hypercoagulability state, lung tissue damage, neurological and/or gastrointestinal tract involvement, monocytic/macrophage activation syndrome, culminating in exaggerated cytokine secretion, called "cytokine storm", which leads to worsening and death. These systemic conditions may be associated with cutaneous lesions, that have polymorphic aspects, where at histopathological level show involvement in different skin changes. These lesions may be associated with multisystemic manifestations that could occur due to angiotensin-converting enzyme 2 receptor and transmembrane serine protease action, allowing the pulmonary infection and possibly skin manifestation. Several reports in literature show cutaneous lesions similar to chilblain, urticarial eruptions, diffuse or disseminated erythema, livedo racemosa, blue toe syndrome, retiform purpura, vesicle trunk, purpuric exanthema or exanthema with clinical aspects of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) and others. Conclusions This review describes the complexity of Covid-19, pathophysiological and clinical aspects, dermatological finding and other dermatological conditions associated with SARS-CoV-2 infection or COVID-19.

show abstract

Telemedicine and support groups could be used to improve adherence to treatment and health‐related quality of life in patients affected by inflammatory skin conditions during the COVID‐19 pandemic

Abstract: The COVID-19 pandemic has made social distancing necessary, and as a result, daily outpatient departments (OPDs) are at a standstill because of the rules imposed by many governments to close all nonessential OPDs. Teledermatology has been advised by few authorities but it is

Cited by 36 publications

References 4 publications

Teledermatology for acne during COVID‐19: high patients’ satisfaction in spite of the emergency

Teledermatology for acne during COVID‐19: high patients’ satisfaction in spite of the emergency

Intersecting Pandemics: Impact of SARS-CoV-2 (COVID-19) Protective Behaviors on People Living With HIV, Atlanta, Georgia

Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms

Contact Info

Product

Resources

About